Michael Tippie

Portland, Oregon, US

CEO at Lipidomics, General Partner, Alignment Ventures
Background

About Michael

Serial entrepreneur and seed stage venture capitalist. Seven life science startups behind me, over $400 MM raised. Stints at megafund Norwest Venture Partners and two seed stage funds, exclusively focuaed on life science deals.

Work Experience

CEO

TomegaVax, Inc.

March 2014 - July 2016

Innunotherapy company, Merged with Vir Biotechnology in fall, 2016.$150 MM Series A anniunced 1/17.

Education

MIT

SM

1987 - 1989

University of Washington

MS, Chemistry

1983 - 1985

Reed College

BS, Chemistry

1975 - 1980